Affiliation:
1. Laboratory of Drugs Sciences, Biomedical Research and Biotechnology, Faculty of Medicine and Pharmacy Hassan II University‐Casablanca Casablanca Morocco
2. Center for Bioequivalence Studies of the Sheikh Zaid Foundation Rabat Morocco
3. Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy Biopharmaceutical and Toxicological Analysis Research Team, Mohammed V University Rabat Morocco
Abstract
AbstractThis study investigates the pharmacokinetic properties and bioequivalence of 2 formulations of clopidogrel tablets administered to a cohort of healthy Moroccan male volunteers. The primary objective was to assess the rate and extent of drug absorption from the test formulation in comparison to a reference formulation, focusing on critical parameters including maximum plasma concentration (Cmax), area under the concentration‐time curve from 0 to the last measurable time (AUC0‐t), and area under the concentration‐time curve extrapolated to infinity (AUC0‐∞). The results revealed that the geometric mean ratios of Cmax, AUC0‐t, and AUC0–∞ for the test formulation relative to the reference formulation were 105.7%, 105.6%, and 105.6%, respectively. The 90% confidence intervals for these parameters fell within the predefined bioequivalence range of 80%‐125%, indicating a statistically and clinically equivalent performance between the 2 formulations. This investigation sheds light on the pharmacokinetic behavior of clopidogrel in the context of the Moroccan male population, offering valuable insights into the comparability of formulations.